Study Stopped
Termination of study by the Sponsor (Central Sugars Refinery Sdn. Bhd. Malaysia)
Effects of Antioxidant Sugar vs Granulated Sugar on Metabolic Outcomes in Healthy and Cardio Metabolic Subjects
MSS
1: Effects of Antioxidant-rich Sugar as Alternative Compared to Granulated Sugar on Gene Expression and Other Metabolic Parameters in Healthy Subjects 2: Effectiveness of Education Module to Modify Sugar Consumption Among Individuals With Cardio Metabolic Risk
1 other identifier
interventional
50
1 country
1
Brief Summary
Study 1: To investigate the effects of antioxidant-rich sugar as alternative compared to granulated sugar on gene expression and other metabolic parameters in healthy subjects. The hypotheses is antioxidant-rich sugar have positive effects on reducing inflammatory cytokines, oxidative stress biomarkers and other metabolic parameters in intervention group compared to control group. Study 2: To evaluate the effectiveness of a nutrition education module in modifying sugar consumption and other CMR-related outcomes in individuals with cardiometabolic risk. The hypotheses is the nutrition education module significantly improves the sugar consumption and other CMR-related outcomes in the intervention groups compared to the control group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFebruary 8, 2023
February 1, 2023
4 months
January 15, 2021
February 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Study 1: Gene expression of inflammation biomarkers (interleukin-6)
Change from baseline in gene expression of interleukin-6 in micrograms at 8th weeks.
8 weeks
Study 1: Gene expression of inflammation biomarkers (TNF-α)
Change from baseline in gene expression of TNF-α in picograms per milliliter at 8th weeks.
8 weeks
Study 1: Gene expression of inflammation biomarkers (CPR)
Change from baseline in gene expression of CPR in milligram per liter at 8th weeks.
8 weeks
Study 1: Gene expression of oxidative stress biomarkers (MDA)
Change from baseline in gene expression of MDA in millimolar at 8th weeks.
8 weeks
Study 1: Gene expression of oxidative stress biomarkers (SOD)
Change from baseline in gene expression of SOD in Units per milliliter at 8th weeks.
8 weeks
Study 1: Gene expression of oxidative stress biomarkers (CAT)
Change from baseline in gene expression of CAT in nanomoles at 8th weeks.
8 weeks
Study 2: Change from baseline in sugar consumption
Dietary sugar intake will be determined using a 3-day food record and semi-quantitative FFQ of added sugar intake. Total sugar (grams per day) in foods will be calculated using formula \[(total sugar (grams) - natural sugar (grams)\]. The total added sugar intake will be divided into four centiles i.e., 25th percentile \[\<10.3g (2 tsps.)\], 50th percentile \[10.3-23.8g (2-5 tsps.)\], 75th percentile \[23.8-47.0g (5-9 tsps.)\] and 100th percentiles \[\>47g (9 tsps.)\].
3 months
Study 2: Change from baseline in sugar consumption
Dietary sugar intake will be determined using a 3-day food record and semi-quantitative FFQ of added sugar intake. Total sugar (grams per day) in foods will be calculated using formula \[(total sugar (grams) - natural sugar (grams)\]. The total added sugar intake will be divided into four centiles i.e., 25th percentile \[\<10.3g (2 tsps.)\], 50th percentile \[10.3-23.8g (2-5 tsps.)\], 75th percentile \[23.8-47.0g (5-9 tsps.)\] and 100th percentiles \[\>47g (9 tsps.)\].
6 months
Secondary Outcomes (51)
Study 1: Inflammation biomarkers (interleukin-6)
8 weeks
Study 1: Inflammation biomarkers (TNF-α)
8 weeks
Study 1: Inflammation biomarkers (CPR)
8 weeks
Study 1: Oxidative stress biomarkers (MDA)
8 weeks
Study 1: Oxidative stress biomarkers (SOD)
8 weeks
- +46 more secondary outcomes
Study Arms (5)
Study 1: Normal sugar
NO INTERVENTIONControl group will be required to continue consuming normal sugar intake for 8 weeks.
Study 1:Minimally refined brown sugar (MRBS)
EXPERIMENTALIntervention group will be required to consume MRBS as added sugar based on their habitual diet for 8 weeks intervention.
Study 2: Normal sugar intake
NO INTERVENTION\- The control group will have no intervention and will continue with their normal daily intake for six months.
Study 2: White sugar
EXPERIMENTAL* Intervention group I will be advised to reduce sugar intake to no more than 10% from total energy intake. * Intervention group I will be given white sugar for daily usage. * Participants in this group will be exposed to the nutrition education module (45 minutes per session, once a week) for six months, attend lecture classes and communicate with health educators through communication applications. * For the first three months, one-to-one diet counseling will be conducted. * Participants' intake of free sugar, as well as other nutrients (carbohydrate, protein, fats, fibre and others) will be closely monitored to ensure compliance to dietary recommendations.
Study 2: MRBS
EXPERIMENTAL* Intervention group II will be advised to reduce sugar intake to no more than 10% from total energy intake. * Intervention group II will be given MRBS for daily usage. * Participants in this group will be exposed to the nutrition education module (45 minutes per session, once a week) for six months, attend lecture classes and communicate with health educators through communication applications. * For the first three months, one-to-one diet counseling will be conducted. * Participants' intake of free sugar, as well as other nutrients (carbohydrate, protein, fats, fibre and others) will be closely monitored to ensure compliance to dietary recommendations.
Interventions
MRBS as added sugar based on their habitual diet
White sugar for daily usage (\<10% daily energy intake)
MRBS for daily usage (\<10% daily energy intake)
Eligibility Criteria
You may qualify if:
- Willingness to adhere to study protocol
- Healthy adults to be aged between 18 and 60 years in both genders
- Being non-smoker
- Body mass index (BMI) between 23 - 26.9 kg/m2 (overweight).
You may not qualify if:
- Present of any kidney, liver and/or inflammatory disease (inflammatory bowel disease, Rheumatoid arthritis and etc.), thyroid disorder, diabetes (Type 1 \& Type 2), cardiovascular or metabolic disease
- Individuals with impaired glucose tolerance or with fasting blood glucose level that more than 5.2 mmol/L
- Pregnancy or lactation
- Alcohol consumption, food allergy
- Individuals who are on regular antioxidant, anti-inflammatory and /or anti-obesity drugs, receiving any glucose lowering and/or lipid lowering medications
- Change in the diet and physical activity (significant weight changes during study period)
- Subjects who habitually consumed beverages rich in sugar such as milo, Teh tarik more than 500 ml, (as tested with the FFQ)
- Study 2:
- Candidates will be screened for:
- Cardiometabolic risk factors (waist circumference, blood pressure, fasting blood glucose, triglyceride and high-density lipoprotein cholesterol)
- Pregnancy or breast feeding
- Mental health status
- Daily total sugar intake
- Malaysian, aged ≥18-59 years old
- Able to read, write and communicate well either in Malay or English
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Putra Malaysia
Serdang, Selangor, 43400, Malaysia
Related Publications (1)
Chiang WL, Mohd Yusof BN, Azlan A, Ismail IZ, Abu Zaid Z. Impacts of a nutrition education intervention in individuals with cardiometabolic risk: Protocol of a randomized controlled trial. Clin Nutr ESPEN. 2022 Jun;49:536-543. doi: 10.1016/j.clnesp.2022.03.037. Epub 2022 Mar 31.
PMID: 35623864DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Dr Barakatun Nisak Mohd Yusof
Study Record Dates
First Submitted
January 15, 2021
First Posted
February 3, 2021
Study Start
February 1, 2022
Primary Completion
June 1, 2022
Study Completion
July 1, 2022
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share